TUA: Telecom Transformer - M1 Merger Makes or Breaks the Future
Tuas Limited analysis: Fair value S$6.82 vs current S$6.89. M1 acquisition creates 32% market share with S$103m synergies. Medium-high risk, 13% expected returns.
View noteTuas Limited analysis: Fair value S$6.82 vs current S$6.89. M1 acquisition creates 32% market share with S$103m synergies. Medium-high risk, 13% expected returns.
View noteTrajan Group Holdings trades at $0.76 versus $1.64 fair value, offering 116% upside through operational leverage and innovation commercialisation in analytical instrumentation markets.
View noteTPG Telecom analysis: Partnership-enabled transformation creating competitive advantages. Fair value $11.97 vs current $5.17. Strong financial health, narrow moat, medium risk.
View noteTelix Pharmaceuticals analysis: Fair value $17.14 USD vs current $17.50 AUD. High-growth radiopharmaceutical platform with 51.2% revenue growth, therapeutic pipeline worth $2.8bn risk-adjusted value, though execution risks and 8.4x leverage require careful assessment.
View noteHOLD rating with $3.81 fair value vs $4.21 current price. Strong growth prospects offset by integration risks and margin compression pressures.
View noteHOLD rating with $11.59 fair value vs $14.00 current price. Strong infrastructure franchise but elevated leverage and regulatory risks limit upside potential.
View noteSouthern Cross Austereo analysis: BUY rating, $3.15 fair value vs $0.84 current price. Digital transformation progressing with LiSTNR profitability achieved.
View noteSuper Retail Group trades at $16.21 vs fair value $13.56, facing digital disruption and margin pressure across four-brand specialty retail portfolio with 55% thesis failure probability.
View noteService Stream trades at $2.07 vs $3.09 fair value (49% upside). EBITDA margins expanding to 6.5%, ROIC 13.2%, net cash $74m.
View noteTrading at $1.48 vs $2.61 fair value (76% upside). Transform-UTM private brand validates strategic transformation. 25% market share, 89 NPS, debt-free balance sheet.
View noteHOLD rating with $8.31 fair value. Exceptional 46.2% EBITDA margins face inevitable compression as 74% ROIC attracts competition. Income-focused opportunity only.
View noteHOLD rating with $1.78 fair value vs $1.99 current price. Strong 80% annuity model offset by margin compression risks and 53% valuation premium to peers.
View note